- SAGE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-Q/A Filing
Sage Therapeutics (SAGE) 10-Q/A2015 Q2 Quarterly report (amended)
Filed: 30 Oct 15, 12:00am
Exhibit 31.1
CERTIFICATIONS
I, Jeffrey M. Jonas, M.D., certify that:
1. | I have reviewed this quarterly report on Form 10-Q/A, Amendment No. 1, of Sage Therapeutics, Inc.; and |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report. |
Date: October 30, 2015 | /s/ Jeffrey M. Jonas | |||
Jeffrey M. Jonas, M.D. | ||||
Chief Executive Officer, President and Director (Principal Executive Officer) |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.